Nestle S.A. said Thursday that it may cut up to 400 of 550 jobs at its Galderma research and development center in southern France.
The decision comes during a review of its global operations, a company spokesman said. In late August, Nestle said it would cease operations of a skincare-product factory in Switzerland, resulting in the loss of 190 jobs.
Nestle plans to offer about 300 of the 550 employees at the R&D center in Sophia Antipolis a voluntary leave package. Another 100 could be transferred to a new biologics and systemic-treatments center, the spokesman said.
The news was first reported by Reuters.
The Swiss company is under pressure to satisfy investors and has been the target of activist investor Third Point LLC THPT After taking a $3.5 billion stake in Nestle, the hedge fund outlined a number of changes the consumer-goods company could make in June, including improving margins, innovating its core business and selling noncore assets as well as its 23% stake in French cosmetics company L’Oreal SA.
In response, Nestle announced cost-cutting efforts and possible divestitures.
By Max Bernhard
Source: MarketWatch
Consumer healthcare firm Haleon has appointed Tate & Lyle executive Dawn Allen as its new chief financial officer, effective 1 November 2024. Allen will succeed Tobias Hestler, who has decided to step down from the role, citing a long-term health condition, the company said.
The group said that the bottling line, which adds 6,500 square metres to the existing 60,700-square-metre site, is the next necessary stage in the company’s international development. The leading brand in Campari Group’s global sales, demand for the Italian bitter apéritif has grown by 500% in the last decade.
The partnership will see Coca-Cola adopt new technology to foster innovation and productivity globally. Through the deal, Coca-Cola has made a $1.1 billion commitment to the Microsoft Cloud and its generative AI capabilities.
